Tus kws kho mob
QP33-26 Update for New-to-Market Medical Drugs: lunsotogene parvec-cwha
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2026
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 4151 - 4160 ntawm 4303
Tus kws kho mob
QP32-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2026
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2026
Tus kws kho mob
QP31-26 MHCP Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2026
Tus kws kho mob
QP30-26 Commercial Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2026
Tus kws kho mob
QP38-26 MHCP Pharmacy Benefit Exclusion for Avopef™, Epioxa™ HD/Epioxa, Fesilty™, Midazolam, Photrexa®, and Wainua®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026
Tus kws kho mob
QP37-26 Commercial Pharmacy Benefit Exclusion for Epioxa™ HD/Epioxa, Fensolvi®, Fesilty™, Midazolam, Photrexa®, Wainua®, Zemaira®, and Zoladex®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026
Tus kws kho mob
QP36-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026